Literature DB >> 10613729

Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts.

K K Kuo1, N Sato, K Mizumoto, N Maehara, H Yonemasu, C G Ker, P C Sheen, M Tanaka.   

Abstract

During mitosis, 2 centrosomes ensure accurate assembly of bipolar spindles and fidelity of the chromosomal segregation. The presence of more than 2 copies of centrosomes during mitosis can result in the formation of multipolar spindles, unbalanced chromosome segregation, and aneuploidy. Recent studies have provided evidence that centrosome hyperamplification plays a pivotal role in carcinogenesis. Using immunofluorescence analysis with gamma-tubulin and pericentrin antibodies, paraffin-embedded sections from 40 malignant biliary diseases including gallbladder cancers (GC; n = 13), intrahepatic cholangiocellular carcinoma (CCC; n = 19), and extrahepatic bile duct cancers (BDC; n = 8) were examined. Thirty-seven benign biliary diseases including chronic cholecystitis, gallbladder adenoma, hepatolithiasis, and choledochal cyst were included as benign controls. The frequencies of the centrosome abnormalities were 70% for GC, 58% for CCC, and 50% for BDC, respectively. The frequencies of centrosome abnormalities in malignant biliary diseases were significantly higher than in their benign counterparts (GC, CCC, BDC; P =.001,.002, and.001, respectively). The results of current study also indicated that biliary malignancy in the advanced stage (III-IV) displayed a higher frequency of centrosome abnormalities than in the early stage (I-II) (P <.001). We conclude that abnormalities in size, number, and shape of the centrosome are frequently observed in biliary tract malignancy. Centrosome abnormalities started to occur in the early stage of biliary malignancy and became very frequent in the advanced stage. This implies that centrosome abnormality might relate to the transition from early to advanced malignancy in biliary malignancy.

Entities:  

Mesh:

Year:  2000        PMID: 10613729     DOI: 10.1002/hep.510310112

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

Review 1.  How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity.

Authors:  Padmashree C G Rida; Guilherme Cantuaria; Michelle D Reid; Omer Kucuk; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

2.  Clinical implication of centrosome amplification in plasma cell neoplasm.

Authors:  Wee J Chng; Greg J Ahmann; Kim Henderson; Rafael Santana-Davila; Philip R Greipp; Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Shaji Kumar; S Vincent Rajkumar; John A Lust; Robert A Kyle; Steven R Zeldenrust; Suzanne R Hayman; Rafael Fonseca
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

3.  Krüppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage.

Authors:  Hong S Yoon; Amr M Ghaleb; Mandayam O Nandan; Irfan M Hisamuddin; William Brian Dalton; Vincent W Yang
Journal:  Oncogene       Date:  2005-06-09       Impact factor: 9.867

Review 4.  Centrosome amplification and the origin of chromosomal instability in breast cancer.

Authors:  Jeffrey L Salisbury; Antonino B D'Assoro; Wilma L Lingle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

5.  Utility of DNA flow cytometry in distinguishing between malignant and benign intrahepatic biliary lesions.

Authors:  Kwun Wah Wen; Peter S Rabinovitch; Dongliang Wang; Aras N Mattis; Linda D Ferrell; Won-Tak Choi
Journal:  Virchows Arch       Date:  2020-04-15       Impact factor: 4.064

Review 6.  Centrosomes and myeloma; aneuploidy and proliferation.

Authors:  Wee J Chng; Rafael Fonseca
Journal:  Environ Mol Mutagen       Date:  2009-10       Impact factor: 3.216

Review 7.  A clinical overview of centrosome amplification in human cancers.

Authors:  Jason Yongsheng Chan
Journal:  Int J Biol Sci       Date:  2011-10-16       Impact factor: 6.580

8.  Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers.

Authors:  Vaishali Pannu; Karuna Mittal; Guilherme Cantuaria; Michelle D Reid; Xiaoxian Li; Shashikiran Donthamsetty; Michelle McBride; Sergey Klimov; Remus Osan; Meenakshi V Gupta; Padmashree C G Rida; Ritu Aneja
Journal:  Oncotarget       Date:  2015-04-30

Review 9.  Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer.

Authors:  German A Pihan
Journal:  Front Oncol       Date:  2013-11-12       Impact factor: 6.244

Review 10.  Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.

Authors:  Karuna Mittal; Jaspreet Kaur; Meghan Jaczko; Guanhao Wei; Michael S Toss; Emad A Rakha; Emiel Adrianus Maria Janssen; Håvard Søiland; Omer Kucuk; Michelle Dian Reid; Meenakshi V Gupta; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2020-10-26       Impact factor: 9.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.